Cargando…

Long-term statin use in patients with lung cancer and dyslipidemia reduces the risk of death

BACKGROUND: Clinical studies have obtained inconsistent results of statin use on cancer outcomes. This study investigated the association between statin use and lung cancer mortality. RESULTS: The use of statin decreased mortality (hazard ratio = 0.91; 95% confidence interval: 0.86–0.96; P < .01)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Wen-Yen, Li, Chia-Hsiang, Lin, Cheng-Li, Liang, Ji-An
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5173128/ https://www.ncbi.nlm.nih.gov/pubmed/27283991 http://dx.doi.org/10.18632/oncotarget.9906

Ejemplares similares

Statins Improve Long Term Patency of Arteriovenous Fistula for Hemodialysis
por: Chang, Hao-Hsiang, et al.
Publicado: (2016)

The role of dyslipidemia and statins in venous thromboembolism
por: Ray, Joel G, et al.
Publicado: (2001)

Long-term statin persistence is poor among high-risk patients with dyslipidemia: a real-world administrative claims analysis
por: Toth, Peter P., et al.
Publicado: (2019)

Impact of metformin on statin‐associated myopathy risks in dyslipidemia patients
por: Bak, Keunhyeong, et al.
Publicado: (2023)

New Drugs for Treating Dyslipidemia: Beyond Statins
por: Ahn, Chang Ho, et al.
Publicado: (2015)

Apolipoprotein E polymorphisms contribute to statin response in Chinese ASCVD patients with dyslipidemia
por: Zhang, Lei, et al.
Publicado: (2019)

Prevalence and types of persistent dyslipidemia in patients treated with statins
por: Reiner, Željko, et al.
Publicado: (2013)

Factors influencing dyslipidemia in statin-treated patients in Lebanon and Jordan: results of the Dyslipidemia International Study
por: Azar, Sami T, et al.
Publicado: (2014)

Post-Diagnostic Statin Use Reduces Mortality in South Korean Patients with Dyslipidemia and Gastrointestinal Cancer
por: Han, Kyu-Tae, et al.
Publicado: (2021)

Short-term statin treatment reduces, and long-term statin treatment abolishes chronic vascular injury by radiation therapy
por: Ait-Aissa, Karima, et al.
Publicado: (2023)

Statins Reduces the Risk of Dementia in Patients with Late-Onset Depression: A Retrospective Cohort Study
por: Yang, Ya-Hsu, et al.
Publicado: (2015)

Expanding the therapeutic landscape: ezetimibe as non-statin therapy for dyslipidemia
por: Lee, Jeongmin, et al.
Publicado: (2023)

Statin Use Reduces Prostate Cancer All-Cause Mortality: A Nationwide Population-Based Cohort Study
por: Sun, Li-Min, et al.
Publicado: (2015)

Statins use and female lung cancer risk in Taiwan
por: Lai, Shih-Wei, et al.
Publicado: (2012)

Statin Therapy Is Associated with Reduced Risk of Peptic Ulcer Disease in the Taiwanese Population
por: Lin, Chun-Jung, et al.
Publicado: (2017)

Omega-3 carboxylic acids monotherapy and combination with statins in the management of dyslipidemia
por: Benes, Lane B, et al.
Publicado: (2016)

The Different Cardiovascular Outcomes Between Long-Term Efficacy of Hydrophilic and Lipophilic Statin Therapy in Both Asian Diabetic Sexes
por: Li, Shang-Yi, et al.
Publicado: (2019)

Effect of Lipid-Testing Interval on Stoke Risk among Newly Diagnosed Dyslipidemia Patients Initiated on Statins
por: Ko, Ahryoung, et al.
Publicado: (2019)

Statin action favors normalization of the plasma lipidome in the atherogenic mixed dyslipidemia of MetS: potential relevance to statin-associated dysglycemia
por: Meikle, Peter J., et al.
Publicado: (2015)

Treatment of Dyslipidemia with Statins and Physical Exercises: Recent Findings of Skeletal Muscle Responses
por: Bonfim, Mariana Rotta, et al.
Publicado: (2015)

Central obesity and atherogenic dyslipidemia in metabolic syndrome are associated with increased risk for colorectal adenoma in a Chinese population
por: Liu, Chiu-Shong, et al.
Publicado: (2010)

Gestational diabetes and long-term risk for dyslipidemia: a population-based historical cohort study
por: Chodick, Gabriel, et al.
Publicado: (2020)

Statin treatment effectiveness and the SLCO1B1*5 reduced function genotype: Long‐term outcomes in women and men
por: Türkmen, Deniz, et al.
Publicado: (2022)

Statin therapy reduces oxidized low density lipoprotein level, a risk factor for stroke outcome
por: Tsai, Nai-Wen, et al.
Publicado: (2014)

Atherogenic dyslipidemia in metabolic syndrome and type 2 diabetes: therapeutic options beyond statins
por: Tenenbaum, Alexander, et al.
Publicado: (2006)

Management of dyslipidemias with fibrates, alone and in combination with statins: role of delayed-release fenofibric acid
por: Moutzouri, Elisavet, et al.
Publicado: (2010)

Does Adjuvant Treatment With Ginkgo Biloba to Statins Have Additional Benefits in Patients With Dyslipidemia?
por: Fan, Yu, et al.
Publicado: (2018)

Association of CETP Gene Variants with Atherogenic Dyslipidemia Among Thai Patients Treated with Statin
por: Srisawasdi, Pornpen, et al.
Publicado: (2021)

A Comparison of Statin Treatment Algorithms Based on the ACC/AHA and Philippine Guidelines for Primary Prevention of Dyslipidemia in Statin-Naive Filipino Patients
por: Maglinte, Bayani Pocholo, et al.
Publicado: (2022)

Differential residual dyslipidemia/cardiovascular risk after statin treatment between Asian-Indians and western whites. Call for action
por: Athyros, Vasilios Gabriel, et al.
Publicado: (2016)

Statins and the Risk of Lung Cancer: A Meta-Analysis
por: Tan, Min, et al.
Publicado: (2013)

Long-Term Use of Statins Lowering the Risk of Rehospitalization Caused by Ischemic Stroke Among Middle-Aged Hyperlipidemic Patients: A Population-Based Study
por: Yin, Jiu-Haw, et al.
Publicado: (2021)

Fenofibric acid: a new fibrate approved for use in combination with statin for the treatment of mixed dyslipidemia
por: Alagona, Peter
Publicado: (2010)

Efficacy of Statin Monotherapy or in Combination With Coenzyme A Capsule in Patients With Metabolic Syndrome and Mixed Dyslipidemia
por: Lai, Jiangtao, et al.
Publicado: (2015)

Efficacy of Moderate Intensity Statins in the Treatment of Dyslipidemia in Korean Patients with Type 2 Diabetes Mellitus
por: Kong, Sung Hye, et al.
Publicado: (2017)

Dyslipidemia and risk of renal replacement therapy or death in incident pre-dialysis patients
por: Voskamp, Pauline W. M., et al.
Publicado: (2018)

Long-term statin therapy is associated with severe coronary artery calcification
por: Ngamdu, Kyari Sumayin, et al.
Publicado: (2023)

Long-term effect of statins on the risk of new-onset osteoporosis: A nationwide population-based cohort study
por: Lin, Tsung-Kun, et al.
Publicado: (2018)

Use of statins and the risk of dementia and mild cognitive impairment: A systematic review and meta-analysis
por: Chu, Che-Sheng, et al.
Publicado: (2018)

Dietary Patterns in Relation to Components of Dyslipidemia and Fasting Plasma Glucose in Adults with Dyslipidemia and Elevated Fasting Plasma Glucose in Taiwan
por: Lin, Li-Yin, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_uuqmmn7b62no6iqjsi0095lcq8